Quick Takeaways
- Madison Avenue Partners, LP filed SCHEDULE 13G for Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (the "Common Stock") (KROS).
- Disclosed ownership: 6.4%.
- Date of event: 07 May 2025.
Quoteable Key Fact
"Madison Avenue Partners, LP disclosed 6.4% ownership in Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (the "Common Stock") (KROS) on 07 May 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Madison Avenue Partners, LP | 6.4% | 2,614,402 | 0 | 2,614,402 | /s/ Eli Samaha | Eli Samaha, as Managing Member of EMAI Management, LLC, the General Partner of Madison Avenue Partners, LP | |
| Madison Avenue International LP | 6.4% | 2,614,402 | 0 | 2,614,402 | /s/ Eli Samaha | Eli Samaha, as Manager of Madison Avenue GP, LLC, the General Partner of Madison Avenue International LP | |
| EMAI Management, LLC | 6.4% | 2,614,402 | 0 | 2,614,402 | /s/ Eli Samaha | Eli Samaha, as Managing Member | |
| Madison Avenue GP, LLC | 6.4% | 2,614,402 | 0 | 2,614,402 | /s/ Eli Samaha | Eli Samaha, as Manager | |
| Caraway Jackson Investments LLC | 6.4% | 2,614,402 | 0 | 2,614,402 | /s/ Eli Samaha | Eli Samaha, as Member | |
| Eli Samaha | 6.4% | 2,614,402 | 0 | 2,614,402 | /s/ Eli Samaha | Eli Samaha |